文献速递肝病消化道肿瘤与早癌

肝移植后饮用咖啡对肝硬化相关肝细胞癌的保护作用

Protective effects of coffee consumption following liver transplantation for hepatocellular carcinoma in cirrhosis.
PubMed 文献 · Aliment Pharmacol Ther · 2019-01-01

该研究评估肝细胞癌(HCC)患者原位肝移植(OLT)前后咖啡摄入与HCC复发的关系,并体外分析咖啡因对腺苷A2AR介导的HCC细胞增殖与转移潜能的影响。90例患者中16例(17.8%)复发,术后咖啡摄入≥3杯/天与总生存改善相关(HR=0.2936,95%CI=0.12-0.71,P=0.006)。

要点

  • 术后咖啡摄入≥3杯/天者总生存优于摄入较少或不摄入者(M=11.0年 vs M=7.48年,P=0.029)。
  • 多因素分析中术后咖啡摄入是总生存风险降低的主要因素(HR=0.2936,95%CI=0.12-0.71,P=0.006)。
  • 咖啡摄入与HCC复发风险降低相关,作者认为可能与咖啡因拮抗腺苷A2AR介导的促HCC细胞生长效应有关。

核心结论

  • 咖啡摄入与OLT后HCC复发风险降低及生存改善相关。
  • 作者认为该结果可能至少部分与咖啡因拮抗腺苷A2AR介导的HCC细胞生长促进效应有关。

研究设计与样本

  • 评估HCC患者OLT前后咖啡摄入并与HCC复发进行相关性分析。
  • 体外用腺苷处理HepG2细胞(加或不加腺苷受体拮抗剂)分析增殖与转移潜能,并检测腺苷受体表达及MAPK、NF-kappa B等腺苷介导的癌症通路。
  • 共90例患者接受OLT治疗HCC。

主要发现

  • 16例(17.8%)患者在中位11.5个月(范围1-40.5)后出现HCC复发。
  • 多因素分析中术后咖啡摄入是总生存风险降低的主要因素(HR=0.2936,95%CI=0.12-0.71,P=0.006)。
  • 术后咖啡摄入≥3杯/天者总生存长于摄入较少或不摄入者(M=11.0年,SD=0.52年 vs M=7.48年,SD=0.76年,P=0.029)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Increasing evidence suggests that coffee consumption might protect against hepatocellular carcinoma (HCC) and liver cirrhosis-associated death risk. Caffeine is a natural antagonist to extracellular adenosine and exhibits experimental tumoricidal activity. AIM: To evaluate if coffee consumption has beneficial effects on HCC recurrence after orthotopic liver transplantation (OLT). METHODS: Coffee consumption of patients before and after OLT for HCC was assessed and correlated with HCC recurrence. HepG2 cells were analysed for proliferation and metastasis potential after treatment with adenosine, in the presence or absence of adenosine receptor antagonists. Expression of adenosine receptors was determined, and known adenosine-mediated cancer pathways inclusive of MAPK and NF-kappa B were tested. RESULTS: Ninety patients underwent OLT for HCC. Sixteen (17.8%) patients experienced HCC recurrence after median time of 11.5 months (range 1-40.5). For overall survival postoperative coffee intake emerged as major factor of hazard reduction in a multivariate analysis (HR = 0.2936, 95% CI = 0.12-0.71, P = 0.006). Those with such postoperative coffee intake (≥3 cups per day) had a longer overall survival than those who consumed less or no coffee: M = 11.0 years, SD = 0.52 years vs. M = 7.48 years, SD = 0.76 years = 4.7, P = 0.029). CONCLUSIONS: Coffee consumption is associated with a decreased risk of HCC recurrence and provides for increased survival following OLT. We suggest that these results might be, at least in part, associated with the antagonist activity of caffeine on adenosine-A2AR mediated growth-promoting effects on HCC cells.

来源:Aliment Pharmacol Ther,查看原文。版权归原作者所有。

引用

  1. Wiltberger G, Wu Y, Lange U, et al. Protective effects of coffee consumption following liver transplantation for hepatocellular carcinoma in cirrhosis. Aliment Pharmacol Ther. 2019. PMID: 30811647. doi:10.1111/apt.15089

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。